• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Director Rahman Jill A was granted 68,795 units of Ordinary Shares (SEC Form 4)

    5/2/25 9:31:48 PM ET
    $AMCR
    Miscellaneous manufacturing industries
    Consumer Discretionary
    Get the next $AMCR alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Rahman Jill A

    (Last) (First) (Middle)
    101 OAKLEY STREET

    (Street)
    EVANSVILLE IN 47710

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Amcor plc [ AMCR ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    04/30/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Ordinary Shares 04/30/2025 A(1) 68,795 A (2) 68,795 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Restricted Stock Units (5) 04/30/2025 A(1) 15,167 (3) (3) Common Stock 15,167 (3) 15,167 D
    Restricted Stock Units (5) 04/30/2025 A 9,317 (4) (4) Common Stock 9,317 (4) 9,317 D
    Explanation of Responses:
    1. Upon closing of the merger of Berry Global Group Inc. ("Berry") with the Issuer ("Amcor"), the Reporting Person received Ordinary Shares and Amcor Restricted Stock Units ("RSUs") in exchange for the Reporting Person's Berry Common Stock, Berry RSUs, and Options to acquire Berry Common Stock ("Berry Options").
    2. Represents Ordinary Shares received in exchange for shares of Berry Common Stock and vested Berry Options.
    3. Represents 15,167 Amcor RSUs received in exchange for 2,092 unvested Berry RSUs, which Amcor RSUs will vest on November 22, 2025, subject to the Reporting Person's service with Amcor through such date.
    4. Represents 9,317 Amcor RSUs which vest on December 2, 2025, subject to the Reporting Person's service with Amcor through such date.
    5. Each RSU represents a contingent right to receive one ordinary share of Amcor upon vesting of the RSUs.
    /s/ Damien Clayton, as attorney-in-fact for Jill A. Rahman 05/02/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $AMCR alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AMCR

    DatePrice TargetRatingAnalyst
    4/22/2025Mkt Perform
    Raymond James
    2/3/2025Hold → Buy
    Jefferies
    1/6/2025$11.00 → $12.00Neutral → Buy
    Citigroup
    1/6/2025$10.00 → $12.00Hold → Buy
    Truist
    12/11/2024$12.50Underperform → Buy
    BofA Securities
    11/27/2024Neutral → Outperform
    Macquarie
    7/9/2024$10.80Hold
    Stifel
    6/28/2024$9.80Equal Weight
    Wells Fargo
    More analyst ratings